Europe’s attempt to unify rules on clinical trials in the 2001 Directive is widely acknowledged to be a disaster. After years of debate, the Commission’s proposals for reform are getting a favourable reception, but it is critical the new regulation takes account of emerging technologies
Members of the European Parliament assess the strengths and weaknesses - and question aspects of the Commission’s Horizon 2020 plan
Brussels should deal only with the broad overarching strategy of the EU’s R&D agenda, with new scientific steering committees appointed to see to the details, key MEPs tell Science|Business
EU lawmakers want leading figures in Europe’s research and innovation programmes to make regular appearances before Parliament, influential MEPs tell Science|Business
Strasbourg should become the EU’s innovation capital, say MEPs. The proposal is an attempt to break the deadlock with France about the seat of the European Parliament